Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Apex Healthcare Bhd's annualizedNet Income for the quarter that ended in Sep. 2025 was RM62.4 Mil. Apex Healthcare Bhd's average total tangible assets for the quarter that ended in Sep. 2025 was RM998.3 Mil. Therefore, Apex Healthcare Bhd's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2025 was 6.25%.
The historical rank and industry rank for Apex Healthcare Bhd's Return-on-Tangible-Asset or its related term are showing as below:
XKLS:7090'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.51 Med: 9.38 Max: 42.83
Current: 6.51
During the past 13 years, Apex Healthcare Bhd's highest Return-on-Tangible-Asset was 42.83%. The lowest was 6.51%. And the median was 9.38%.
XKLS:7090's Return-on-Tangible-Asset is not ranked
in the Medical Distribution industry.
Industry Median: 2.305
vs XKLS:7090: 6.51
Apex Healthcare Bhd (XKLS:7090) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Apex Healthcare Bhd Return-on-Tangible-Asset Related Terms
Apex Healthcare Bhd Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd Return-on-Tangible-Asset Chart
XKLS:7090 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Sep. 2025) net income data.
What does a Return-on-Tangible-Asset of 6.25% mean?
Apex Healthcare Bhd (XKLS:7090) has a Return-on-Tangible-Asset of 6.25% as of Sep. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Apex Healthcare Bhd and its competitors. This is 33% below median its historical median of 9.38. Over the past decade, Apex Healthcare Bhd's Return-on-Tangible-Asset has ranged from 6.51 to 42.83.
Is Apex Healthcare Bhd's Return-on-Tangible-Asset too high?
Apex Healthcare Bhd's current Return-on-Tangible-Asset of 6.25% is 33% below median its 10-year median of 9.38. Over the past 10 years, this metric has ranged from a low of 6.51 to a high of 42.83. The Medical Distribution industry median Return-on-Tangible-Asset is 2.31. Apex Healthcare Bhd's value of 6.25% is 171.1% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Return-on-Tangible-Asset compare to MCK and COR?
Apex Healthcare Bhd's Return-on-Tangible-Asset of 6.25% can be compared against companies in the Medical Distribution industry. The industry median Return-on-Tangible-Asset is 2.31. Apex Healthcare Bhd's value of 6.25% is 171.1% above this benchmark. Historically, Apex Healthcare Bhd's own Return-on-Tangible-Asset has ranged from 6.51 to 42.83 over the past decade. While the company's 10-year median is 9.38 vs. the industry median of 2.31, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.31, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Return-on-Tangible-Asset of 6.25% is 171.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Return-on-Tangible-Asset is 6.25%, which is 33% below median its own 10-year median of 9.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Return-on-Tangible-Asset of 6.25%. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Return-on-Tangible-Asset is 6.25%, which is 33% below median its 10-year median of 9.38 and 171.1% above the Medical Distribution industry median of 2.31. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Return-on-Tangible-Asset is 6.25% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
Return-on-Tangible-Asset: 6.25% (33% below median its 10-year median of 9.38)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 171.1% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
